Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

EPIGENETICS

Many XCI-ting routes to reach the eXACT dose

Nature Cell Biology volume 22, pages 1397–1398 (2020)Cite this article

Subjects

X-chromosome inactivation studies have revealed striking species specificities in terms of the players, kinetics and mechanisms. Transcriptomic profiling of human pre‐implantation development and germ cell differentiation suggests a peculiar dosage compensation mechanism with yet undefined contributions from XIST and XACT lncRNAs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Models for X-chromosome activity control during human development.

References

  1. Sangrithi, M. N. & Turner, J. M. A. BioEssays 40, e1800024 (2018).

    Article  PubMed  Google Scholar 

  2. Petropoulos, S. et al. Cell 165, 1012–1026 (2016).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Sahakyan, A. et al. Cell Stem Cell 20, 87–101 (2017).

    Article  CAS  PubMed  Google Scholar 

  4. Chitiashvili, T. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-020-00607-4 (2020).

  5. Patrat, C., Ouimette, J. F. & Rougeulle, C. Development 147, dev183095 (2020).

    Article  CAS  PubMed  Google Scholar 

  6. Vallot, C. et al. Nat. Genet. 45, 239–241 (2013).

    Article  CAS  PubMed  Google Scholar 

  7. Vallot, C. et al. Cell Stem Cell 20, 102–111 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Casanova, M. et al. Nat. Commun. 10, 5652 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Vértesy, Á. et al. Nat. Commun. 9, 1873 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Mandal, S. et al. Stem Cell Reports 14, 745–754 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Moreira de Mello, J. C., Fernandes, G. R., Vibranovski, M. D. & Pereira, L. V. Sci. Rep. 7, 10794 (2017).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sangrithi, M. N. et al. Dev. Cell 40, 289–301.e3 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Lucchesi, J. C. J. Genet. 97, 357–364 (2018).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Université de Paris, Epigenetics and Cell Fate, CNRS, Paris, France

    Jean-François Ouimette & Claire Rougeulle

Authors
  1. Jean-François Ouimette
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claire Rougeulle
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claire Rougeulle.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ouimette, JF., Rougeulle, C. Many XCI-ting routes to reach the eXACT dose. Nat Cell Biol 22, 1397–1398 (2020). https://doi.org/10.1038/s41556-020-00608-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41556-020-00608-3

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing